Abstract
BackgroundSingle case series suggested that RTx in AAV complicated by end-stage renal disease (ESRD) is safe and effective for graft and AAV outcome. Limited data are available with respect to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
